Company Overview of MaxCyte, Inc.
Key Executives for MaxCyte, Inc.
|Douglas Arthur Doerfler||119 Relationships||Co-Founder, Chief Executive Officer, President and Director||61|
|Ronald Evan Holtz CPA||7 Relationships||Company Secretary, CFO & Executive Director||59|
|Debra K. Bowes M.T||No Relationships||Executive Vice President of Business & Strategic Development||--|
|Brad Calvin||No Relationships||Executive Vice President of Global Commercial Operations||--|
|Claudio Dansky Ullmann||No Relationships||Chief Medical Officer||--|
MaxCyte, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|J. Stark Thompson Ph.D.||7 Relationships||MaxCyte, Inc.||75|
|Douglas Arthur Doerfler||119 Relationships||MaxCyte, Inc.||61|
|Ronald Evan Holtz CPA||7 Relationships||MaxCyte, Inc.||59|
|William W. Brooke J.D.||28 Relationships||Wallace, Jordan, Ratcliff & Brandt||60|
|Arthur Michael Mandell||24 Relationships||Prestwick Pharmaceuticals, Inc.||64|
MaxCyte, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee J.D.||William W. Brooke||28 Relationships||2 Executives|
|Compensation Committee Ph.D.||J. Stark Thompson||7 Relationships||3 Executives|
|Nominating Committee||Arthur Michael Mandell||24 Relationships||3 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$584.0K|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.